InvestorsHub Logo

The Other Guy

04/28/17 7:56 AM

#4442 RE: BioPharma #4441

Voting yes allows RS as a possibility. The only reason to RS is to maintain Nasdaq compliance if nothing else brings the stock price above $1.

Voting NO says to management they need to figure it out or get off Nasdaq. Neither of those options would be negative to shareholders.